Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
Saved in:
| Main Authors: | Xian Lin, Jian Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1578971/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing old natural compounds to target new pathogens: honokiol and magnolol against Candida auris
by: Mihai Mares, et al.
Published: (2024-12-01) -
Polymer-Free Electrospinning of β-Cyclodextrin–Oligolactide for Magnolol and Honokiol Pharmaceutical Formulations
by: Diana-Andreea Blaj, et al.
Published: (2025-01-01) -
Inhibition of Bovine Enterovirus Infection by Magnolol via Modulating the Gut Microbiota in Mice
by: Junying Hu, et al.
Published: (2025-05-01) -
Honokiol inhibits human osteosarcoma MG63 cell migration by upregulating FTO and Smad6 to promote autophagy
by: Jian Wu, et al.
Published: (2024-12-01) -
Enhanced penetration and biofilm eradication by sophorolipid micelles encapsulating Honokiol: a comprehensive solution for biofilm-associated lung infections
by: Shiyu Lin, et al.
Published: (2025-02-01)